CBR-470-1
CBR-470-1 is a potent inhibitor of glycolytic phosphoglycerate kinase 1 (PGK1) that activates NRF2 by increasing methylglyoxal levels. CBR-470-1 is a non-covalent Nrf2 activator with neuroprotective activity that protects SH-SY5Y neuronal cells from MPP+-induced cytotoxicity by activating the Keap1-Nrf2 cascade. cytotoxicity induced by MPP+.
Product Specifications
CAS Number
2416095-06-0
Stability
≥ 2 years
Purity
>98% (HPLC)
Weight
365.9
Molecular Formula
C14H20ClNO4S2
Notes
Research use only, not for human use.
Receptor
Nrf2
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
GTR15137445 1 Vial
Lentiviral human SLC4A1AP shRNA (UAS) - Lentiviral human SLC4A1AP shRNA (UAS, GFP) (100)
Ask
View Details 
041453-AP 200 µL
SCD5, ID (SCD5, ACOD4, SCD4, Stearoyl-CoA desaturase 5, Acyl-CoA-desaturase 4, HSCD5, Stearoyl-CoA 9-desaturase) (AP) discontinued
Ask
View Details 